Exploring Ibogaine: Risks and Benefits

Ibogaine, a psychoactive compound, shows promise in treating addiction but carries significant risks. Learn more about its effects and research.
Tewksbury Hospital Reports Fourth Assault After Security Policy Change

Following a new security policy, Tewksbury Hospital has reported multiple violent incidents, raising concerns about safety in mental health facilities.
Prenatal Medications Linked to Autism Risk: Study Insights

This article discusses a study linking prenatal medication use to autism risk, analyzing over 6 million maternal-child health records.
Texas Behavioral Health Provider Data Breach Affects 285,000

Dallas-based North Texas Behavioral Health Authority reports a major data breach threatening patient information of over 285,000 individuals, with ongoing investigations.
Zócalo Health Secures $22.7M to Support Latino Care

Zócalo Health, focused on Latino patients, has raised $22.7 million to improve integrated care across mental health and primary care.
Medicaid Cuts Force Autism Learning Partners to Halt Services in NY

Following significant Medicaid rate cuts, Autism Learning Partners has suspended new patient intake, affecting access to autism treatment in New York.
Kratom’s Impact on Addiction Treatment and Regulation

The rise of kratom and its potent derivative, 7-OH, poses new challenges for addiction treatment providers in the U.S.
Innovative VR Therapy for Autism: FloreoRx FDA Review

FloreoRx, an innovative virtual reality therapy, seeks FDA approval to support autistic individuals in developing vital social skills.
Trump Accelerates Psychedelic Drug Approvals for Mental Health

A new executive order by President Trump aims to expedite the research and approval of psychedelic drugs to address serious mental illnesses.
New Digital Mental Health Tools Library Launched

APA Labs has introduced a library of evaluated digital mental health technologies to assist clinicians and health systems.